Treatment with gabapentinoids—a group of drugs used for epilepsy, nerve pain and anxiety disorders—is associated with an increased risk of suicidal behaviour, unintentional overdose, injuries, and road traffic incidents, finds a study from Sweden published by The BMJ today.
* This article was originally published here
